Global Lysosomal Storage Disease (LSD) Market Insights, Forecast to 2028

  • Report ID:186771
  • Industry Name: Medical Care
  • Publishing Date: Apr-22
  • No. of Pages: 108
                              
Lysosomal Storage Disease (LSD) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Lysosomal Storage Disease (LSD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Lipid Metabolism Disorder Glycoprotein Metabolism Disorder Segment by Application Hospitals Clinics Others By Company Actelion Pharmaceuticals Amicus Therapeutics Arena Pharmaceuticals Astellas Pharma Astrazeneca Biomarin Pharmaceutical Eli Lilly Lexicon Pharmaceuticals Novo Nordisk Merck By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Lipid Metabolism Disorder 1.2.3 Glycoprotein Metabolism Disorder 1.3 Market by Application 1.3.1 Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Lysosomal Storage Disease (LSD) Market Perspective (2017-2028) 2.2 Lysosomal Storage Disease (LSD) Growth Trends by Region 2.2.1 Lysosomal Storage Disease (LSD) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Lysosomal Storage Disease (LSD) Historic Market Size by Region (2017-2022) 2.2.3 Lysosomal Storage Disease (LSD) Forecasted Market Size by Region (2023-2028) 2.3 Lysosomal Storage Disease (LSD) Market Dynamics 2.3.1 Lysosomal Storage Disease (LSD) Industry Trends 2.3.2 Lysosomal Storage Disease (LSD) Market Drivers 2.3.3 Lysosomal Storage Disease (LSD) Market Challenges 2.3.4 Lysosomal Storage Disease (LSD) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Lysosomal Storage Disease (LSD) Players by Revenue 3.1.1 Global Top Lysosomal Storage Disease (LSD) Players by Revenue (2017-2022) 3.1.2 Global Lysosomal Storage Disease (LSD) Revenue Market Share by Players (2017-2022) 3.2 Global Lysosomal Storage Disease (LSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Lysosomal Storage Disease (LSD) Revenue 3.4 Global Lysosomal Storage Disease (LSD) Market Concentration Ratio 3.4.1 Global Lysosomal Storage Disease (LSD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Disease (LSD) Revenue in 2021 3.5 Lysosomal Storage Disease (LSD) Key Players Head office and Area Served 3.6 Key Players Lysosomal Storage Disease (LSD) Product Solution and Service 3.7 Date of Enter into Lysosomal Storage Disease (LSD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Lysosomal Storage Disease (LSD) Breakdown Data by Type 4.1 Global Lysosomal Storage Disease (LSD) Historic Market Size by Type (2017-2022) 4.2 Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Type (2023-2028) 5 Lysosomal Storage Disease (LSD) Breakdown Data by Application 5.1 Global Lysosomal Storage Disease (LSD) Historic Market Size by Application (2017-2022) 5.2 Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Lysosomal Storage Disease (LSD) Market Size (2017-2028) 6.2 North America Lysosomal Storage Disease (LSD) Market Size by Type 6.2.1 North America Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) 6.2.2 North America Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) 6.2.3 North America Lysosomal Storage Disease (LSD) Market Share by Type (2017-2028) 6.3 North America Lysosomal Storage Disease (LSD) Market Size by Application 6.3.1 North America Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) 6.3.2 North America Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) 6.3.3 North America Lysosomal Storage Disease (LSD) Market Share by Application (2017-2028) 6.4 North America Lysosomal Storage Disease (LSD) Market Size by Country 6.4.1 North America Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) 6.4.2 North America Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Lysosomal Storage Disease (LSD) Market Size (2017-2028) 7.2 Europe Lysosomal Storage Disease (LSD) Market Size by Type 7.2.1 Europe Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) 7.2.2 Europe Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) 7.2.3 Europe Lysosomal Storage Disease (LSD) Market Share by Type (2017-2028) 7.3 Europe Lysosomal Storage Disease (LSD) Market Size by Application 7.3.1 Europe Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) 7.3.2 Europe Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) 7.3.3 Europe Lysosomal Storage Disease (LSD) Market Share by Application (2017-2028) 7.4 Europe Lysosomal Storage Disease (LSD) Market Size by Country 7.4.1 Europe Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) 7.4.2 Europe Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size (2017-2028) 8.2 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Type 8.2.1 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Lysosomal Storage Disease (LSD) Market Share by Type (2017-2028) 8.3 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Application 8.3.1 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Lysosomal Storage Disease (LSD) Market Share by Application (2017-2028) 8.4 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Region 8.4.1 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Lysosomal Storage Disease (LSD) Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Lysosomal Storage Disease (LSD) Market Size (2017-2028) 9.2 Latin America Lysosomal Storage Disease (LSD) Market Size by Type 9.2.1 Latin America Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) 9.2.2 Latin America Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) 9.2.3 Latin America Lysosomal Storage Disease (LSD) Market Share by Type (2017-2028) 9.3 Latin America Lysosomal Storage Disease (LSD) Market Size by Application 9.3.1 Latin America Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) 9.3.2 Latin America Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) 9.3.3 Latin America Lysosomal Storage Disease (LSD) Market Share by Application (2017-2028) 9.4 Latin America Lysosomal Storage Disease (LSD) Market Size by Country 9.4.1 Latin America Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) 9.4.2 Latin America Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size (2017-2028) 10.2 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Type 10.2.1 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Lysosomal Storage Disease (LSD) Market Share by Type (2017-2028) 10.3 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Application 10.3.1 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Lysosomal Storage Disease (LSD) Market Share by Application (2017-2028) 10.4 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Country 10.4.1 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Actelion Pharmaceuticals 11.1.1 Actelion Pharmaceuticals Company Details 11.1.2 Actelion Pharmaceuticals Business Overview 11.1.3 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Introduction 11.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.1.5 Actelion Pharmaceuticals Recent Developments 11.2 Amicus Therapeutics 11.2.1 Amicus Therapeutics Company Details 11.2.2 Amicus Therapeutics Business Overview 11.2.3 Amicus Therapeutics Lysosomal Storage Disease (LSD) Introduction 11.2.4 Amicus Therapeutics Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.2.5 Amicus Therapeutics Recent Developments 11.3 Arena Pharmaceuticals 11.3.1 Arena Pharmaceuticals Company Details 11.3.2 Arena Pharmaceuticals Business Overview 11.3.3 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Introduction 11.3.4 Arena Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.3.5 Arena Pharmaceuticals Recent Developments 11.4 Astellas Pharma 11.4.1 Astellas Pharma Company Details 11.4.2 Astellas Pharma Business Overview 11.4.3 Astellas Pharma Lysosomal Storage Disease (LSD) Introduction 11.4.4 Astellas Pharma Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.4.5 Astellas Pharma Recent Developments 11.5 Astrazeneca 11.5.1 Astrazeneca Company Details 11.5.2 Astrazeneca Business Overview 11.5.3 Astrazeneca Lysosomal Storage Disease (LSD) Introduction 11.5.4 Astrazeneca Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.5.5 Astrazeneca Recent Developments 11.6 Biomarin Pharmaceutical 11.6.1 Biomarin Pharmaceutical Company Details 11.6.2 Biomarin Pharmaceutical Business Overview 11.6.3 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Introduction 11.6.4 Biomarin Pharmaceutical Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.6.5 Biomarin Pharmaceutical Recent Developments 11.7 Eli Lilly 11.7.1 Eli Lilly Company Details 11.7.2 Eli Lilly Business Overview 11.7.3 Eli Lilly Lysosomal Storage Disease (LSD) Introduction 11.7.4 Eli Lilly Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.7.5 Eli Lilly Recent Developments 11.8 Lexicon Pharmaceuticals 11.8.1 Lexicon Pharmaceuticals Company Details 11.8.2 Lexicon Pharmaceuticals Business Overview 11.8.3 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Introduction 11.8.4 Lexicon Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.8.5 Lexicon Pharmaceuticals Recent Developments 11.9 Novo Nordisk 11.9.1 Novo Nordisk Company Details 11.9.2 Novo Nordisk Business Overview 11.9.3 Novo Nordisk Lysosomal Storage Disease (LSD) Introduction 11.9.4 Novo Nordisk Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.9.5 Novo Nordisk Recent Developments 11.10 Merck 11.10.1 Merck Company Details 11.10.2 Merck Business Overview 11.10.3 Merck Lysosomal Storage Disease (LSD) Introduction 11.10.4 Merck Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) 11.10.5 Merck Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Lipid Metabolism Disorder Table 3. Key Players of Glycoprotein Metabolism Disorder Table 4. Global Lysosomal Storage Disease (LSD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Lysosomal Storage Disease (LSD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Lysosomal Storage Disease (LSD) Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Lysosomal Storage Disease (LSD) Market Share by Region (2017-2022) Table 8. Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Lysosomal Storage Disease (LSD) Market Share by Region (2023-2028) Table 10. Lysosomal Storage Disease (LSD) Market Trends Table 11. Lysosomal Storage Disease (LSD) Market Drivers Table 12. Lysosomal Storage Disease (LSD) Market Challenges Table 13. Lysosomal Storage Disease (LSD) Market Restraints Table 14. Global Lysosomal Storage Disease (LSD) Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Lysosomal Storage Disease (LSD) Revenue Share by Players (2017-2022) Table 16. Global Top Lysosomal Storage Disease (LSD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Disease (LSD) as of 2021) Table 17. Ranking of Global Top Lysosomal Storage Disease (LSD) Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Lysosomal Storage Disease (LSD) Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Lysosomal Storage Disease (LSD) Product Solution and Service Table 21. Date of Enter into Lysosomal Storage Disease (LSD) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Lysosomal Storage Disease (LSD) Revenue Market Share by Type (2017-2022) Table 25. Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Lysosomal Storage Disease (LSD) Revenue Market Share by Type (2023-2028) Table 27. Global Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Lysosomal Storage Disease (LSD) Revenue Share by Application (2017-2022) Table 29. Global Lysosomal Storage Disease (LSD) Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Lysosomal Storage Disease (LSD) Revenue Share by Application (2023-2028) Table 31. North America Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Lysosomal Storage Disease (LSD) Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Lysosomal Storage Disease (LSD) Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size by Country (2023-2028) & (US$ Million) Table 61. Actelion Pharmaceuticals Company Details Table 62. Actelion Pharmaceuticals Business Overview Table 63. Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Product Table 64. Actelion Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 65. Actelion Pharmaceuticals Recent Developments Table 66. Amicus Therapeutics Company Details Table 67. Amicus Therapeutics Business Overview Table 68. Amicus Therapeutics Lysosomal Storage Disease (LSD) Product Table 69. Amicus Therapeutics Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 70. Amicus Therapeutics Recent Developments Table 71. Arena Pharmaceuticals Company Details Table 72. Arena Pharmaceuticals Business Overview Table 73. Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Product Table 74. Arena Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 75. Arena Pharmaceuticals Recent Developments Table 76. Astellas Pharma Company Details Table 77. Astellas Pharma Business Overview Table 78. Astellas Pharma Lysosomal Storage Disease (LSD) Product Table 79. Astellas Pharma Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 80. Astellas Pharma Recent Developments Table 81. Astrazeneca Company Details Table 82. Astrazeneca Business Overview Table 83. Astrazeneca Lysosomal Storage Disease (LSD) Product Table 84. Astrazeneca Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 85. Astrazeneca Recent Developments Table 86. Biomarin Pharmaceutical Company Details Table 87. Biomarin Pharmaceutical Business Overview Table 88. Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Product Table 89. Biomarin Pharmaceutical Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 90. Biomarin Pharmaceutical Recent Developments Table 91. Eli Lilly Company Details Table 92. Eli Lilly Business Overview Table 93. Eli Lilly Lysosomal Storage Disease (LSD) Product Table 94. Eli Lilly Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 95. Eli Lilly Recent Developments Table 96. Lexicon Pharmaceuticals Company Details Table 97. Lexicon Pharmaceuticals Business Overview Table 98. Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Product Table 99. Lexicon Pharmaceuticals Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 100. Lexicon Pharmaceuticals Recent Developments Table 101. Novo Nordisk Company Details Table 102. Novo Nordisk Business Overview Table 103. Novo Nordisk Lysosomal Storage Disease (LSD) Product Table 104. Novo Nordisk Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 105. Novo Nordisk Recent Developments Table 106. Merck Company Details Table 107. Merck Business Overview Table 108. Merck Lysosomal Storage Disease (LSD) Product Table 109. Merck Revenue in Lysosomal Storage Disease (LSD) Business (2017-2022) & (US$ Million) Table 110. Merck Recent Developments Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Lysosomal Storage Disease (LSD) Market Share by Type: 2021 VS 2028 Figure 2. Lipid Metabolism Disorder Features Figure 3. Glycoprotein Metabolism Disorder Features Figure 4. Global Lysosomal Storage Disease (LSD) Market Share by Application: 2021 VS 2028 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Others Case Studies Figure 8. Lysosomal Storage Disease (LSD) Report Years Considered Figure 9. Global Lysosomal Storage Disease (LSD) Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Lysosomal Storage Disease (LSD) Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Lysosomal Storage Disease (LSD) Market Share by Region: 2021 VS 2028 Figure 12. Global Lysosomal Storage Disease (LSD) Market Share by Players in 2021 Figure 13. Global Top Lysosomal Storage Disease (LSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Disease (LSD) as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Lysosomal Storage Disease (LSD) Revenue in 2021 Figure 15. North America Lysosomal Storage Disease (LSD) Market Size YoY (2017-2028) & (US$ Million) Figure 16. North America Lysosomal Storage Disease (LSD) Market Size Market Share by Type (2017-2028) Figure 17. North America Lysosomal Storage Disease (LSD) Market Size Market Share by Application (2017-2028) Figure 18. North America Lysosomal Storage Disease (LSD) Market Size Share by Country (2017-2028) Figure 19. United States Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Lysosomal Storage Disease (LSD) Market Size YoY (2017-2028) & (US$ Million) Figure 22. Europe Lysosomal Storage Disease (LSD) Market Size Market Share by Type (2017-2028) Figure 23. Europe Lysosomal Storage Disease (LSD) Market Size Market Share by Application (2017-2028) Figure 24. Europe Lysosomal Storage Disease (LSD) Market Size Share by Country (2017-2028) Figure 25. Germany Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Lysosomal Storage Disease (LSD) Market Size YoY (2017-2028) & (US$ Million) Figure 32. Asia Pacific Lysosomal Storage Disease (LSD) Market Size Market Share by Type (2017-2028) Figure 33. Asia Pacific Lysosomal Storage Disease (LSD) Market Size Market Share by Application (2017-2028) Figure 34. Asia Pacific Lysosomal Storage Disease (LSD) Market Size Share by Region (2017-2028) Figure 35. China Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Japan Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. South Korea Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Southeast Asia Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. India Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Australia Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 41. Latin America Lysosomal Storage Disease (LSD) Market Size YoY (2017-2028) & (US$ Million) Figure 42. Latin America Lysosomal Storage Disease (LSD) Market Size Market Share by Type (2017-2028) Figure 43. Latin America Lysosomal Storage Disease (LSD) Market Size Market Share by Application (2017-2028) Figure 44. Latin America Lysosomal Storage Disease (LSD) Market Size Share by Country (2017-2028) Figure 45. Mexico Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Brazil Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Middle East & Africa Lysosomal Storage Disease (LSD) Market Size YoY (2017-2028) & (US$ Million) Figure 48. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size Market Share by Type (2017-2028) Figure 49. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size Market Share by Application (2017-2028) Figure 50. Middle East and Africa Lysosomal Storage Disease (LSD) Market Size Share by Country (2017-2028) Figure 51. Turkey Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. UAE Lysosomal Storage Disease (LSD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 55. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 56. Arena Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 57. Astellas Pharma Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 58. Astrazeneca Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 59. Biomarin Pharmaceutical Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 60. Eli Lilly Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 61. Lexicon Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 62. Novo Nordisk Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 63. Merck Revenue Growth Rate in Lysosomal Storage Disease (LSD) Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.